[Cholesterolic gallstones. Pathophysiology and treatment (author's transl)].
D001647:Bile Acids and Salts / Q000378:metabolism; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use; D002763:Cholecystectomy; D002769:Cholelithiasis / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D002784:Cholesterol / Q000096:biosynthesis / Q000378:metabolism*; D002790:Cholesterol 7-alpha-Hydroxylase / Q000502:physiology; D002994:Clofibrate / Q000009:adverse effects; D045166:Estradiol Congeners / Q000009:adverse effects; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000502:physiology; D007082:Ileum / Q000601:surgery; D008099:Liver / Q000201:enzymology; D009765:Obesity / Q000150:complications; D010743:Phospholipids / Q000378:metabolism; D045167:Progesterone Congeners / Q000009:adverse effects; D014628:Vagotomy / Q000009:adverse effects
D001647:Bile Acids and Salts; D045166:Estradiol Congeners; D010743:Phospholipids; D045167:Progesterone Congeners; D002635:Chenodeoxycholic Acid; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D002790:Cholesterol 7-alpha-Hydroxylase; D002994:Clofibrate
La lithiase biliaire à cholestérol. Physiopathologie et traitement.